ARTICLE
13 March 2025

Artificial Intelligence In Healthcare (Video)

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
The Buchanan Healthcare Industry Group and Advanced Technology Team presents "Artificial Intelligence in Healthcare."
United States Food, Drugs, Healthcare, Life Sciences

The Buchanan Healthcare Industry Group and Advanced Technology Team presents "Artificial Intelligence in Healthcare."

Artificial Intelligence (AI) and models of all sorts are changing the way providers diagnose, treat, and monitor patients in both inpatient and outpatient contexts. Medicine and its larger ecosystem present unique opportunities and challenges for AI. The regulatory environment likewise has evolved to meet new paradigms for software as a medical device and similar domains. In this panel discussion, we brought together CEOs of the largest med-tech accelerator, a leading multi-national medical device and software maker, and a major academic health system to discuss these developments and their perspectives.

View the recording here or below.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More